FDA Adverse Event Injury Summary report: N

FLEXTEND II

MDR report key: 1951485 · Received January 6, 2011

Report

Report Number
2124215-2010-23051
Event Type
Injury
Date Received
January 6, 2011
Date of Event
June 1, 2010
Report Date
November 26, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
PMA / PMN Number
NOTAPVD
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE PATIENT WAS HOSPITALIZED AND TREATED FOR THE EFFUSION. THIS LEAD STILL REMAINS IMPLANTED AND IN SERVICE. NO ADDITIONAL INFORMATION IS AVAILABLE. IF ANY ADDITIONAL INFORMATION DOES BECOME AVAILABLE, THIS REPORT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS IMPLANTABLE RIGHT VENTRICULAR (RV) LEAD EXPERIENCED SHORTNESS OF BREATH AND A PLEURAL EFFUSION. IT IS UNKNOWN IF THE EFFUSION WAS A RESULT OF THE IMPLANTATION PROCESS. NO OTHER ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXTEND II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4097

Patients

Seq Age Sex Outcome Treatment
1 Life Threatening| R